Chimerix inc stock

Apr 07, 2020 · Chimerix Inc (NASDAQ:CMRX) shares were up 5.3% on Monday . The company traded as high as $1.44 and last traded at $1.40, approximately 270,416 shares were traded during mid-day trading. A decline of 40% from the average daily volume of 447,579 shares. The stock had previously closed at $1.33. A number of equities research analysts […]

Dr. Alrutz joined Chimerix in 2012 and was named Vice President, General Counsel in September 2014. From 2002 to 2011, Dr. Alrutz was counsel to Trimeris, Inc. (NASDAQ: TRMS), serving in a variety of in-house positions, most recently as General Counsel. Chimerix Inc. Stock Price (CXF) | Barron's Mar 27, 2020 · View today's stock price, news and analysis for Chimerix Inc. (CXF). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. CMRX Institutional Ownership - Chimerix, Inc. Stock CMRX / Chimerix, Inc. / Arrowpoint Asset Management, LLC Passive Investment. 04-10 sec.gov - 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Chimerix, Inc. (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) 16934W106 (CUSIP Number) March … Chimerix | Crunchbase

View a financial market summary for CMRX including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CMRX (Chimerix Inc.) stock.

How Does Chimerix, Inc. (CMRX) Stack Up For Investors? On Monday Do Analysts Recommend You Should Buy Chimerix, Inc. (CMRX) Stock? On Friday  28 Dec 2015 Chimerix Stock Plunges After Anti-Infection Drug Fails Phase 3 Trial Durham, NC-based Chimerix (NASDAQ: CMRX) said Monday that its drug 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy,  Profile for Chimerix, Inc. (CMRX). « Back to company index. CMRX Chatter Timeline. Stock Ticker for CMRX. Most Active Tweeters for CMRX. User, Tweets. In consideration for the license rights, Cantex received an upfront cash payment of $30 million plus 10 million shares of Chimerix common stock and is eligible to  

28 Dec 2015 Chimerix Stock Plunges After Anti-Infection Drug Fails Phase 3 Trial Durham, NC-based Chimerix (NASDAQ: CMRX) said Monday that its drug 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, 

Chimerix, Inc. Common Stock (CMRX) Stock Quotes | Nasdaq Mar 31, 2020 · Chimerix, Inc. Common Stock (CMRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. CMRX:NASDAQ GM Stock Quote - Chimerix Inc - Bloomberg Markets Stock analysis for Chimerix Inc (CMRX:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. CMRX | Chimerix Inc. Stock Price & News - WSJ View the latest Chimerix Inc. (CMRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

View a financial market summary for CMRX including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CMRX (Chimerix Inc.) stock.

Profile for Chimerix, Inc. (CMRX). « Back to company index. CMRX Chatter Timeline. Stock Ticker for CMRX. Most Active Tweeters for CMRX. User, Tweets. In consideration for the license rights, Cantex received an upfront cash payment of $30 million plus 10 million shares of Chimerix common stock and is eligible to   Chimerex, Inc. (NASDAQ: CMRX) stock research, profile, news, analyst ratings, Chimerix Presents Updated Results From Phase 2 Clinical Trial Of DSTAT In  8 Apr 2019 April 08, 2019 17:00 ET | Source: Chimerix, Inc. April 8, 2019, Chimerix's Board of Directors granted Mr. Sherman a stock option to purchase 

Chimerix - CMRX - Stock Price & News | The Motley Fool

CHIMERIX INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K). Envoyer par e-mail. 02/25/2020 | 02:18 pm. CMRX Stock Price | Chimerix Inc. Stock Quote (U.S.: Nasdaq ... Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment Chimerix | Innovative medicines for cancer and other ...

Chimerix Inc. (NASDAQ: CMRX) closed at 1.29 per share at the end of the most recent trading day (a -5.84 % change compared to the prior day closing price) with a volume of 755.11K shares and market capitalization of 83.35M.Is a component of indexes and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 40 people. CXF.DE | Chimerix Inc. Stock Price & News - WSJ View the latest Chimerix Inc. (CXF.DE) stock price, news, historical charts, analyst ratings and financial information from WSJ. CMRX Stock Price Quote & News - Chimerix | Robinhood